Arvee Laboratories (India) Ltd. (ARVEE.NS)
NSE · INR · Basic Materials · Specialty Chemicals
₹178.58 (+4.28%) as of
Key statistics
- Market cap
- 1.97B
- P/E (TTM)
- 48.53
- EPS (TTM)
- 3.68
- Dividend yield
- 0.00%
- 52-week range
- 129.11 – 290.78
- Beta
- 0.50
- Revenue (TTM)
- 412.59M
- Profit margin
- 9.82%
- Volume
- 2.90k
About Arvee Laboratories (India) Ltd.
Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also provides drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4amino pyridine, and 2chloro5nitrobenzoic acid. In addition, the company exports its products. Arvee Laboratories (India) Ltd. was incorporated in 2012 and is based in Ahmedabad, India.
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- Headquarters
- Ahmedabad, India
- Employees
- 57
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.